000 | 01621 a2200481 4500 | ||
---|---|---|---|
005 | 20250513233915.0 | ||
264 | 0 | _c20010412 | |
008 | 200104s 0 0 eng d | ||
022 | _a0959-8049 | ||
024 | 7 |
_a10.1016/s0959-8049(00)00422-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFernebro, E | |
245 | 0 | 0 |
_aPrognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMar 2001 |
||
300 |
_a486-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, Cell Surface _xblood |
650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
650 | 0 | 4 |
_aRectal Neoplasms _xblood |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aMadsen, R R | |
700 | 1 | _aFernö, M | |
700 | 1 | _aBrünner, N | |
700 | 1 | _aBendahl, P | |
700 | 1 | _aChristensen, I J | |
700 | 1 | _aJohnson, A | |
700 | 1 | _aNilbert, M | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 37 _gno. 4 _gp. 486-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(00)00422-6 _zAvailable from publisher's website |
999 |
_c11204063 _d11204063 |